Literature DB >> 19559392

A candidate gene association study of 77 polymorphisms in migraine.

Markus Schürks1, Tobias Kurth, Julie E Buring, Robert Y L Zee.   

Abstract

UNLABELLED: Population-based studies have established an association between migraine and cardiovascular disease (CVD). We sought to investigate whether genetic variants implicated in CVD are associated with migraine. We performed an association study among 25,713 women participating in the Women's Health Study, with information on 77 previously characterized polymorphisms. Migraine and migraine aura status were self-reported. We used logistic regression to investigate the genotype-migraine association. At baseline, 4705 (18.3%) women reported history of migraine; 39.6% of the 3306 women with active migraine indicated aura. Regarding any history of migraine, the multivariable-adjusted odds ratios (95% confidence intervals) for TNF rs673 were 0.52 (0.30 to 0.89), for TGFB1 rs1800469 0.93 (0.89 to 0.98), and for CCR2 rs1799864 1.12 (1.03 to 1.21). Among active migraine with aura, the odds ratios (95% confidence intervals) were 1.35 (1.0 to 1.81) for TNF rs1800750, 1.13 (1.02 to 1.26) for TNF rs1800629, and 1.22 (1.07 to 1.40) for CCR2 rs1799864; among active migraine without aura, 0.9 (0.84 to 0.97) for TGFB1 rs1800469, 1.13 (1.01 to 1.27) for NOS3 rs3918226, and 1.12 (1.02 to 1.24) for IL9 rs2069885. After correction for multiple testing using the false discovery rate, none of the results remained significant. Our data suggest an association of polymorphisms implicated in inflammatory pathways and migraine in women. TNF, CCR2, TGFB1, NOS3, and IL9 warrant further investigation. PERSPECTIVE: This article presents results from an association study of 77 polymorphisms, implicated in CVD, and migraine. Variants in TNF, CCR2, TGFB1, NOS3, and IL9 were found to be associated with migraine but did not remain significant after adjustment for multiple testing. Variations in these genes warrant further investigation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559392      PMCID: PMC2704575          DOI: 10.1016/j.jpain.2009.01.326

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  33 in total

1.  Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE.

Authors:  Yawei Liu; Ingrid Teige; Bryndis Birnir; Shohreh Issazadeh-Navikas
Journal:  Nat Med       Date:  2006-04-23       Impact factor: 53.440

2.  Endothelial nitric oxide synthase (Glu298Asp) polymorphism is an independent risk factor for migraine with aura.

Authors:  Barbara Borroni; Renata Rao; Paolo Liberini; Elisabetta Venturelli; Michela Cossandi; Silvana Archetti; Luigi Caimi; Alessandro Padovani
Journal:  Headache       Date:  2006 Nov-Dec       Impact factor: 5.887

3.  MTHFR C677T polymorphism and migraine with aura.

Authors:  Unda Todt; Jan Freudenberg; Ingrid Goebel; Christian Netzer; Axel Heinze; Katja Heinze-Kuhn; Hartmut Göbel; Christian Kubisch
Journal:  Ann Neurol       Date:  2006-11       Impact factor: 10.422

Review 4.  Pathophysiology of headache--past and present.

Authors:  Michael A Moskowitz
Journal:  Headache       Date:  2007-04       Impact factor: 5.887

5.  A molecular mechanism for the differential regulation of TGF-beta1 expression due to the common SNP -509C-T (c. -1347C > T).

Authors:  Riddhish Shah; Carolyn K Hurley; Phillip E Posch
Journal:  Hum Genet       Date:  2006-08-01       Impact factor: 4.132

6.  The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with migraine without aura.

Authors:  Shahir Mazaheri; Mehrdad Hajilooi; Alireza Rafiei
Journal:  J Neurol       Date:  2006-10-24       Impact factor: 4.849

7.  Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease.

Authors:  Markus Schürks; Robert Y L Zee; Julie E Buring; Tobias Kurth
Journal:  Neurology       Date:  2008-07-30       Impact factor: 9.910

8.  Association of genetic variations with nonfatal venous thrombosis in postmenopausal women.

Authors:  Nicholas L Smith; Lucia A Hindorff; Susan R Heckbert; Rozenn N Lemaitre; Kristin D Marciante; Kenneth Rice; Thomas Lumley; Joshua C Bis; Kerri L Wiggins; Frits R Rosendaal; Bruce M Psaty
Journal:  JAMA       Date:  2007-02-07       Impact factor: 56.272

Review 9.  Migraine and ischaemic heart disease and stroke: potential mechanisms and treatment implications.

Authors:  E Gretchen Tietjen
Journal:  Cephalalgia       Date:  2007-08       Impact factor: 6.292

10.  Genetic and environmental influences on migraine: a twin study across six countries.

Authors:  Elles J Mulder; Caroline Van Baal; David Gaist; Mikko Kallela; Jaakko Kaprio; Dan A Svensson; Dale R Nyholt; Nicholas G Martin; Alex J MacGregor; Lynn F Cherkas; Dorret I Boomsma; Aarno Palotie
Journal:  Twin Res       Date:  2003-10
View more
  17 in total

Review 1.  Chemical mediators of migraine: preclinical and clinical observations.

Authors:  Saurabh Gupta; Stephanie J Nahas; B Lee Peterlin
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

Review 2.  Tumour necrosis factor gene polymorphisms and migraine: a systematic review and meta-analysis.

Authors:  Markus Schürks; Pamela M Rist; Robert Yl Zee; Daniel I Chasman; Tobias Kurth
Journal:  Cephalalgia       Date:  2011-10       Impact factor: 6.292

3.  Association of endothelial nitric oxide synthase gene polymorphisms (894G/T, -786T/C, G10T) and clinical findings in patients with migraine.

Authors:  Recep Eröz; Anzel Bahadir; Suber Dikici; Sener Tasdemir
Journal:  Neuromolecular Med       Date:  2014-05-22       Impact factor: 3.843

Review 4.  Targeted Nitric Oxide Synthase Inhibitors for Migraine.

Authors:  Amynah A Pradhan; Zachariah Bertels; Simon Akerman
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

5.  The TNF-α-308G/A polymorphism is associated with migraine risk: A meta-analysis.

Authors:  Lian Gu; Yan Yan; Jianxiong Long; Li Su; Yanling Hu; Qing Chen; Juanjuan Xie; Guangliang Wu
Journal:  Exp Ther Med       Date:  2012-03-30       Impact factor: 2.447

6.  VDR Gene Polymorphisms and Cluster Headache Susceptibility: Case-Control Study in a Southeastern European Caucasian Population.

Authors:  Maria Papasavva; Michail Vikelis; Vasileios Siokas; Martha-Spyridoula Katsarou; Emmanouil Dermitzakis; Athanasios Raptis; Efthimios Dardiotis; Nikolaos Drakoulis
Journal:  J Mol Neurosci       Date:  2021-09-14       Impact factor: 3.444

7.  Interaction among nitric oxide (NO)-related genes in migraine susceptibility.

Authors:  Flavia M Gonçalves; Marcelo R Luizon; Jose G Speciali; Alisson Martins-Oliveira; Fabiola Dach; Jose E Tanus-Santos
Journal:  Mol Cell Biochem       Date:  2012-08-04       Impact factor: 3.396

8.  Association between endothelial nitric oxide synthase (NOS3) rs2070744 and the risk for migraine.

Authors:  Elena García-Martín; Santiago Navarro-Muñoz; Christopher Rodriguez; Mercedes Serrador; Hortensia Alonso-Navarro; Marisol Calleja; Laura Turpín-Fenoll; Marta Recio-Bermejo; Rafael García-Ruiz; Jorge Millán-Pascual; Francisco Navacerrada; José Francisco Plaza-Nieto; Esteban García-Albea; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  Pharmacogenomics J       Date:  2019-12-03       Impact factor: 3.550

9.  Investigation of TNFA 308G > A and TNFB 252G > A polymorphisms in genetic susceptibility to migraine.

Authors:  Jayashri Ghosh; Gunjan Joshi; S Pradhan; Balraj Mittal
Journal:  J Neurol       Date:  2009-12-25       Impact factor: 4.849

10.  Tumor Necrosis Factor (TNF) -308G>A, Nitric Oxide Synthase 3 (NOS3) +894G>T Polymorphisms and Migraine Risk: A Meta-Analysis.

Authors:  Min Chen; Wenjing Tang; Lei Hou; Ruozhuo Liu; Zhao Dong; Xun Han; Xiaofei Zhang; Dongjun Wan; Shengyuan Yu
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.